Capetti AF - Search Results

1

Salvage therapy or simplification of salvage regimens with dolutegravir plus ritonavir-boosted darunavir dual therapy in highly cART-experienced subjects: an Italian cohort.

Capetti AF, Sterrantino G, Cossu MV, Cenderello G, Cattelan AM, De Socio GV, Rusconi S, Riccardi N, Baldin GM, Cima S, Niero FP, Rizzardini G, Sasset L. Capetti AF, et al. Antivir Ther. 2017;22(3):257-262. doi: 10.3851/IMP3095. Epub 2016 Sep 23. Antivir Ther. 2017. PMID: 27661787

2

Virological treatment failure of highly active antiretroviral therapy in an unselected cohort of HIV-infected patients.

Bonfanti P, Capetti A, Di Mattei P, Niero F, Rizzardini G. Bonfanti P, et al. AIDS. 1998 Jun 18;12(9):1111. AIDS. 1998. PMID: 9662213 No abstract available.

3

HIV disease treatment in the era of HAART.

Bonfanti P, Capetti A, Rizzardini G. Bonfanti P, et al. Biomed Pharmacother. 1999 Mar;53(2):93-105. doi: 10.1016/s0753-3322(99)80066-3. Biomed Pharmacother. 1999. PMID: 10337464 Free article. Review.

4

Simplification of protease inhibitor-containing regimens with efavirenz, nevirapine or abacavir: safety and efficacy outcomes.

Chiesa E, Bini T, Adorni F, Capetti A, Rizzardini G, Faggion I, Mussini C, Sollima S, Melzi S, Bongiovanni M, Tordato F, Cicconi P, Castelnuovo B, Rusconi S, d'Arminio Monforte A. Chiesa E, et al. Antivir Ther. 2003 Feb;8(1):27-35. Antivir Ther. 2003. PMID: 12713061

5

Virological success of lopinavir/ritonavir salvage regimen is affected by an increasing number of lopinavir/ritonavir-related mutations.

Bongiovanni M, Bini T, Adorni F, Meraviglia P, Capetti A, Tordato F, Cicconi P, Chiesa E, Cordier L, Cargnel A, Landonio S, Rusconi S, d'Arminio Monforte A. Bongiovanni M, et al. Antivir Ther. 2003 Jun;8(3):209-14. Antivir Ther. 2003. PMID: 12924537 Clinical Trial.

6

Association between diarrhea and quality of life in HIV-infected patients receiving highly active antiretroviral therapy.

Tramarin A, Parise N, Campostrini S, Yin DD, Postma MJ, Lyu R, Grisetti R, Capetti A, Cattelan AM, Di Toro MT, Mastroianni A, Pignattari E, Mondardini V, Calleri G, Raise E, Starace F; Palladio Study Group. Tramarin A, et al. Qual Life Res. 2004 Feb;13(1):243-50. doi: 10.1023/B:QURE.0000015282.24774.36. Qual Life Res. 2004. PMID: 15058804

7

Drop in plasma lithium levels in 2 patients on concomitant boosted protease inhibitor regimens.

Capetti A, Landonio S, Faggion I, Rizzardini G. Capetti A, et al. J Int Assoc Physicians AIDS Care (Chic). 2006 Sep;5(3):119-20. doi: 10.1177/1545109706288799. J Int Assoc Physicians AIDS Care (Chic). 2006. PMID: 16928881 No abstract available.

8

Switch to abacavir-based triple nucleoside regimens in HIV-1 infected patients never treated with suboptimal antiretroviral therapy: a review.

Rizzardini G, Capetti A. Rizzardini G, et al. Med Sci Monit. 2006 Dec;12(12):RA269-276. Epub 2006 Nov 23. Med Sci Monit. 2006. PMID: 17136016 Review.

9

An immunological comparison of third companion in advanced drug-naive HIV-infected patients.

Rizzardini G, Trabattoni D, Capetti A, Castelletti E, Migliorino M, Panebianco R, Pacei M, Quirino T, Clerici M. Rizzardini G, et al. HIV Clin Trials. 2006 Sep-Oct;7(5):221-8. doi: 10.1310/hct0705-221. HIV Clin Trials. 2006. PMID: 17162315 Clinical Trial.

10

Late HIV seroconversion after non-occupational postexposure prophylaxis against HIV with concomitant hepatitis C virus seroconversion.

Terzi R, Niero F, Iemoli E, Capetti A, Coen M, Rizzardini G. Terzi R, et al. AIDS. 2007 Jan 11;21(2):262-3. doi: 10.1097/QAD.0b013e328011922c. AIDS. 2007. PMID: 17197828 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

112 results

Search Page

Filters